Han Sung Yong, Song Geun Am, Kim Dong Uk, Baek Dong Hoon, Lee Moon Won, Kim Gwang Ha
Department of Internal Medicine, Pusan National University Hospital, Biomedical Research Institute, and Pusan National University School of Medicine, Busan, Korea.
Clin Endosc. 2018 Mar;51(2):201-205. doi: 10.5946/ce.2017.097. Epub 2017 Aug 31.
Combined hepatocellular-cholangiocarcinoma (HCC-CC) with bile duct invasion (BDI) is rare. In unresectable cases, biliary stent placement and photodynamic therapy (PDT) are used for resolving obstructive jaundice. However, stent occlusion remains problematic, and PDT is expensive and time-consuming. Intraductal radiofrequency ablation (RFA) is an emerging procedure for palliation in these patients. It has potential benefits including less expense, lower rates of severe complication, longer maintenance of ductal patency, and easier technique compared with PDT or stenting alone. We report a 67-year-old man who underwent repeated intraductal RFA for HCC-CC and HCC with BDI, for whom bile duct patency was maintained without additional biliary procedures.
合并胆管侵犯(BDI)的肝细胞-胆管癌(HCC-CC)较为罕见。在无法切除的病例中,胆管支架置入和光动力疗法(PDT)用于解决梗阻性黄疸。然而,支架阻塞仍然是个问题,且PDT费用高昂且耗时。导管内射频消融(RFA)是这些患者姑息治疗的一种新兴方法。与单独的PDT或支架置入相比,它具有潜在的优势,包括费用更低、严重并发症发生率更低、导管通畅维持时间更长以及技术操作更简便。我们报告了一名67岁男性,他因HCC-CC和合并BDI的HCC接受了多次导管内RFA治疗,其胆管通畅得以维持,无需额外的胆管手术。